_2020091018165303jzv.jpg "Decoding The World Of ETF")
-
My Account
Partnered by:
Associate Partners:
My Account
Partnered by:
Associate Partners:
Partnered by:
Associate Partners:
BSE Live
Jan 22, 16:00Prev. Close
67.95
Open Price
67.95
Bid Price (Qty.)
69.30 (194924)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Balance Sheet of Bharat Immunologicals and Biologicals Corporation (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 43.18 | 43.18 | 43.18 | 43.18 | 43.18 | |
| Total Share Capital | 43.18 | 43.18 | 43.18 | 43.18 | 43.18 | |
| Reserves and Surplus | -22.71 | -12.50 | -5.68 | -1.43 | -8.07 | |
| Total Reserves and Surplus | -22.71 | -12.50 | -5.68 | -1.43 | -8.07 | |
| Total Shareholders Funds | 20.47 | 30.68 | 37.50 | 41.75 | 35.11 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.48 | 0.00 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.36 | |
| Long Term Provisions | 5.65 | 5.33 | 3.38 | 3.01 | 3.04 | |
| Total Non-Current Liabilities | 5.65 | 5.81 | 3.38 | 3.01 | 3.41 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 3.04 | 32.22 | 0.00 | 0.06 | 9.42 | |
| Trade Payables | 43.53 | 44.18 | 0.42 | 0.29 | 7.71 | |
| Other Current Liabilities | 53.26 | 11.27 | 11.38 | 13.57 | 12.61 | |
| Short Term Provisions | 0.88 | 0.80 | 0.73 | 0.21 | 0.13 | |
| Total Current Liabilities | 100.71 | 88.48 | 12.53 | 14.13 | 29.87 | |
| Total Capital And Liabilities | 126.83 | 124.96 | 53.40 | 58.90 | 68.38 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 4.47 | 4.70 | 4.95 | 5.36 | 5.50 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 4.68 | 4.92 | 5.17 | 5.58 | 5.72 | |
| Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Assets [Net] | 14.00 | 10.01 | 7.93 | 4.24 | 2.47 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.43 | |
| Other Non-Current Assets | 15.13 | 11.30 | 2.10 | 2.29 | 0.00 | |
| Total Non-Current Assets | 33.81 | 26.22 | 15.20 | 12.11 | 8.61 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 51.72 | 14.44 | 1.72 | 0.37 | 22.47 | |
| Trade Receivables | 17.61 | 72.97 | 15.94 | 6.45 | 13.08 | |
| Cash And Cash Equivalents | 12.10 | 7.93 | 20.00 | 39.05 | 20.14 | |
| Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 3.63 | |
| OtherCurrentAssets | 11.59 | 3.39 | 0.53 | 0.91 | 0.45 | |
| Total Current Assets | 93.02 | 98.74 | 38.20 | 46.79 | 59.77 | |
| Total Assets | 126.83 | 124.96 | 53.40 | 58.90 | 68.38 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.04 | 0.66 | 3.96 | 4.35 | 14.65 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 95.12 | 88.03 | 28.03 | 79.41 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | -- | -- | -- | -- | -- | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
06.01.2021
Bharat Immuno Standalone September 2020 Net Sales at Rs 25.36 crore, up 213.02% Y-o-Y
01.11.2019
Bharat Immuno Standalone September 2019 Net Sales at Rs 8.10 crore, up 73.39% Y-o-Y
02.08.2019
Bharat Immuno Standalone June 2019 Net Sales at Rs 7.00 crore, up 7973.59% Y-o-Y
12.04.2019
Bharat Immuno Standalone March 2019 Net Sales at Rs 70.61 crore, up 225.66% Y-o-Y
06.01.2021
Bharat Immuno Standalone September 2020 Net Sales at Rs 25.36 crore, up 213.02% Y-o-Y
01.11.2019
Bharat Immuno Standalone September 2019 Net Sales at Rs 8.10 crore, up 73.39% Y-o-Y
02.08.2019
Bharat Immuno Standalone June 2019 Net Sales at Rs 7.00 crore, up 7973.59% Y-o-Y
12.04.2019
Bharat Immuno Standalone March 2019 Net Sales at Rs 70.61 crore, up 225.66% Y-o-Y
